JPS4985098A - - Google Patents

Info

Publication number
JPS4985098A
JPS4985098A JP48106809A JP10680973A JPS4985098A JP S4985098 A JPS4985098 A JP S4985098A JP 48106809 A JP48106809 A JP 48106809A JP 10680973 A JP10680973 A JP 10680973A JP S4985098 A JPS4985098 A JP S4985098A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48106809A
Other languages
Japanese (ja)
Other versions
JPS5912678B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4985098A publication Critical patent/JPS4985098A/ja
Publication of JPS5912678B2 publication Critical patent/JPS5912678B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP48106809A 1972-09-23 1973-09-21 Method for producing novel pyrimidine derivatives Expired JPS5912678B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7212915 1972-09-23
NLAANVRAGE7212915,A NL176458C (en) 1972-09-23 1972-09-23 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING ACTIVE SUBSTANCES SUITABLE.

Publications (2)

Publication Number Publication Date
JPS4985098A true JPS4985098A (en) 1974-08-15
JPS5912678B2 JPS5912678B2 (en) 1984-03-24

Family

ID=19816997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48106809A Expired JPS5912678B2 (en) 1972-09-23 1973-09-21 Method for producing novel pyrimidine derivatives

Country Status (18)

Country Link
US (1) US3892695A (en)
JP (1) JPS5912678B2 (en)
AR (1) AR203090A1 (en)
AU (1) AU472312B2 (en)
BE (1) BE805178A (en)
CA (1) CA1019733A (en)
CH (1) CH592094A5 (en)
DE (1) DE2347727C2 (en)
DK (1) DK140668B (en)
ES (1) ES418996A1 (en)
FI (1) FI54311C (en)
FR (1) FR2199996B1 (en)
GB (1) GB1445765A (en)
HU (1) HU167206B (en)
IE (1) IE38221B1 (en)
NL (1) NL176458C (en)
SE (1) SE407686B (en)
ZA (1) ZA737131B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL179906C (en) * 1974-02-09 1986-12-01 Akzo Nv PROCESS FOR PREPARING 1,2,3,4,10,14B-HEXAHYDRODIBENZO (C, F) PYRAZINO (1,2-A) AZEPINE DERIVATIVES.
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL7414038A (en) * 1974-10-28 1976-05-03 Akzo Nv NEW TETRACYCLIC PYRROLIDINO DERIVATIVES.
GB1472382A (en) * 1975-01-16 1977-05-04 Wyeth John & Brother Ltd Dibenzopyrimidoazepines
NL7610942A (en) * 1976-10-02 1978-04-04 Akzo Nv PROCESS FOR PREPARING 1,4-DIAZEPINE DERIVATIVES.
NL7809726A (en) * 1978-09-26 1980-03-28 Akzo Nv NEW TETRACYCLIC CONNECTIONS.
HU195491B (en) * 1985-12-20 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
CH678623A5 (en) * 1989-05-17 1991-10-15 Sochinaz Societe Chimique De V Prepn. of di:benzo pyrazino azepine(s)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154511B (en) * 1967-07-07 1977-09-15 Organon Nv PROCESS FOR PREPARING PIPERAZINE DERIVATIVES, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND AND MOLDS PREPARED ACCORDING TO THIS PROCEDURE.
US3470181A (en) * 1967-10-23 1969-09-30 American Home Prod Fused 2-pyrimidinepropionic acid compounds,related compounds,and the process for their preparation

Also Published As

Publication number Publication date
DK140668C (en) 1980-03-24
FR2199996B1 (en) 1977-09-09
GB1445765A (en) 1976-08-11
DE2347727C2 (en) 1986-12-11
ES418996A1 (en) 1976-07-01
HU167206B (en) 1975-09-27
DK140668B (en) 1979-10-22
CH592094A5 (en) 1977-10-14
AU472312B2 (en) 1976-05-20
IE38221L (en) 1974-03-23
CA1019733A (en) 1977-10-25
DE2347727A1 (en) 1974-04-04
FI54311B (en) 1978-07-31
NL7212915A (en) 1974-03-26
FI54311C (en) 1978-11-10
ZA737131B (en) 1974-08-28
SE407686B (en) 1979-04-09
NL176458B (en) 1984-11-16
FR2199996A1 (en) 1974-04-19
AR203090A1 (en) 1975-08-14
IE38221B1 (en) 1978-01-18
JPS5912678B2 (en) 1984-03-24
NL176458C (en) 1985-04-16
BE805178A (en) 1974-03-21
AU6019773A (en) 1975-03-13
US3892695A (en) 1975-07-01

Similar Documents

Publication Publication Date Title
JPS53118434U (en)
FR2199996B1 (en)
JPS4990227A (en)
JPS5729911U (en)
JPS5224575Y2 (en)
JPS4894735U (en)
JPS5128225Y2 (en)
JPS4986392U (en)
JPS4935958A (en)
JPS4893711U (en)
CS157994B1 (en)
JPS48104712U (en)
JPS48104075A (en)
CH573600A5 (en)
CH560959A5 (en)
CH575498B5 (en)
CH575741A5 (en)
CH574146A5 (en)
CH573756A5 (en)
CH576808A5 (en)
CH572682A5 (en)
CH572102A5 (en)
CH576845A5 (en)
CH571764A5 (en)
CH576961A5 (en)